Futura Medical plc (LON:FUM – Get Free Report)’s share price dropped 2.2% during trading on Thursday . The stock traded as low as GBX 2.09 and last traded at GBX 2.20. Approximately 1,432,718 shares traded hands during trading, an increase of 25% from the average daily volume of 1,149,129 shares. The stock had previously closed at GBX 2.25.
Futura Medical Trading Down 20.7%
The company has a 50 day moving average of GBX 4.38 and a 200 day moving average of GBX 7.76. The firm has a market cap of £5.31 million, a price-to-earnings ratio of -0.84 and a beta of 1.25.
Futura Medical (LON:FUM – Get Free Report) last released its quarterly earnings data on Tuesday, September 30th. The company reported GBX (2.17) earnings per share (EPS) for the quarter. Futura Medical had a negative return on equity of 56.44% and a negative net margin of 44.64%. As a group, sell-side analysts anticipate that Futura Medical plc will post 2.8486672 EPS for the current fiscal year.
About Futura Medical
Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.
Sexual health issues are prevalent in both men and women.
Read More
- Five stocks we like better than Futura Medical
- What Are Earnings Reports?
- Rare Earth Stocks: The Truce That Isn’t a Truce
- What is the Nasdaq? Complete Overview with History
- Carving Up Profits: 3 Food Stocks on the Thanksgiving Table
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- C3.ai’s Reset: Why New Leadership Could Spark a Turnaround
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.
